by William Jester | Dec 27, 2021 | News
Please read Drs. Strom and Roy’s article in the Pharmacoepidemiology and Drug Safety titled, “Validation of a claims-based algorithm for identifying non-infectious pneumonitis in patients diagnosed with lung cancer.” Lung cancer is the leading cause...
by William Jester | Dec 24, 2021 | Community, News
Biotechnology company Oxolife S.L. (Spain), the Energy Balance, Puberty and Reproductive Health research group of the University of Cordoba (Spain) and the Human Growth and Reproductive Development research group at Rutgers University have initiated a triple...
by William Jester | Dec 23, 2021 | Community, News
New Jersey may have been an outlier when the United States surpassed 100,000 drug overdose deaths last year, but the Garden State is now on a path toward its own somber milestone in a decade-long epidemic. Preliminary data shows New Jersey is on pace to end 2021 with...
by William Jester | Dec 22, 2021 | Community, Covid, News
An outside panel of scientific advisers to the Food and Drug Administration narrowly recommended the agency authorize the experimental Covid-19 oral antiviral from Merck MRK -0.74% & Co. and partner Ridgeback Biotherapeutics LP. The panel, known as the...
by William Jester | Dec 21, 2021 | Community, Covid, News
With the spread of the COVID-19 Omicron variant, investors across the country have seen substantial hits to their portfolios. Richard Michelfelder, a clinical associate professor in the Rutgers–Camden School of Business whose research focuses on regulation, utility...
